Online citations, reference lists, and bibliographies.

A Polymer-based, Paclitaxel-eluting Stent In Patients With Coronary Artery Disease

Gregg W Stone, Stephen G Ellis, David A. Cox
Published 2004 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share



This paper is referenced by
10.1016/j.jcin.2008.10.001
Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
Michael S Lee (2008)
10.1016/j.jacc.2004.09.040
Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
Gerald S Werner (2004)
10.1093/eurheartj/ehl488
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
Pasi P Karjalainen (2007)
10.3969/j.issn.1671-5411.2013.04.003
Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
Pak-hei Chan (2013)
10.1080/14017430410022948
A cath lab hero is something to be? Comments on left main stem percutaneous coronary intervention for ST-elevation myocardial infarction
Lars Grip (2005)
10.1080/14628840500434958
Drug‐eluting versus third‐generation bare metal stents: The US strategy
Daniel W Isenbarger (2005)
10.1517/14740338.7.5.597
Safety of drug-coated stents
Giuseppe Biondi-Zoccai (2008)
10.1186/1471-2261-7-7
Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: A cross-sectional study
Mohammad Alidoosti (2007)
10.1002/ccd.23031
Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
Xavier Freixa (2012)
10.1111/j.1540-8183.2004.04079.x
Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
S. K. Silber (2004)
10.1007/s00059-007-2891-5
Die Stentthrombose im Fokus von Drug-eluting Stents
Jochen Woehrle (2007)
Herz Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction Present Data from Nonrandomized Studies
Joachim Schofer (2004)
10.1007/s00392-005-0276-4
Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography
Dr. med. L. Buellesfeld (2005)
10.5603/CJ.a2014.0036
Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.
Fumei Huang (2015)
10.1097/MCA.0000000000000131
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies
Nobuaki Kobayashi (2014)
CURRENT STATUS AND FUTURE PERSPECTIVES ON DRUG-ELUTING BIORESORBABLE CORONARY SCAFFOLDS: WILL THE PARADIGM OF PCI SHIFT?
Alfonso Ielasi (2014)
10.1161/CIRCULATIONAHA.104.481283
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.
Gregg W Stone (2005)
On cellular sources for intimal hyperplasia after vascular interventions
Stefan Mellander (2007)
10.1007/s00330-018-5320-7
Coronary plaque characteristics on baseline CT predict the need for late revascularization in symptomatic patients after percutaneous intervention
Mengmeng Yu (2018)
10.1161/CIRCULATIONAHA.105.583484
Prevention of restenosis by systemic drug therapy: back to the future?
Albert Schoemig (2005)
10.1371/journal.pone.0072545
Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
Yunjun Xiao (2013)
10.1016/j.iccl.2016.02.006
Pathology of Endovascular Stents.
Kenta Nakamura (2016)
10.1177/2211068215611040
Local Stent-Based Release of Transforming Growth Factor–β1 Limits Arterial In-Stent Restenosis
David S. Wang (2016)
10.1016/j.athoracsur.2015.07.005
Systematic Review of Therapies for Stable Coronary Artery Disease in Diabetic Patients.
Suvitesh Luthra (2015)
10.1056/NEJMra051091
Coronary-artery stents.
Patrick W. Serruys (2006)
10.1016/j.iccl.2012.11.006
Optimal Stenting in Saphenous Vein Graft Intervention.
Gabriel Maluenda (2013)
10.1093/bmb/ldt009
Coronary stents: historical development, current status and future directions.
Javaid Iqbal (2013)
10.1093/eurheartj/eht496
PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Erik Walter Holy (2014)
Restenosis and drug-eluting stents.
Robert Winslow (2005)
10.2217/ICA.12.33
Techniques for the diagnosis of vertebral artery origin stenosis and considerations for determining treatment and timing
Edgar A Samaniego (2012)
10.1161/CIRCULATIONAHA.105.552190
Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice
Keith D. Dawkins (2005)
10.1161/CIRCOUTCOMES.113.000822
Contemporary Patterns of Discharge Aspirin Dosing After Acute Myocardial Infarction in the United States: Results From the National Cardiovascular Data Registry (NCDR)
Hurst M. Hall (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar